Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| OSAIC HOLDINGS, INC. | GDO Western Asset Global Corporate Opportunity Fund Inc. | 13G/A | 4.7% | Aug 31, 2025 | 6mo |
| OSAIC HOLDINGS, INC. | RSF RiverNorth Capital & Income Fund, Inc. | 13G/A | 9.4% | Jun 30, 2025 | 6mo |
| Rosalind Advisors, Inc. | TLPH Talphera, Inc. | 13G/A | 9.9% | Mar 31, 2025 | 6mo |
| Egor Romanyuk | MCRP Micropolis AI Robotics | 13G | 15.45% | Mar 6, 2025 | 6mo |
| Walden Jon Matthew | HUBC Hub Cyber Security Ltd. | 13G | 8.4% | May 11, 2026 | 6mo |
| Ephraim G Fields | DLPN Dolphin Entertainment, Inc. | 13G | 5.9% | May 11, 2026 | 6mo |
| John C. Malone | LILA Liberty Latin America Ltd. | 13D/A | 8.8% | May 11, 2026 | 6mo |
| Streeterville Management LLC | AEHL Antelope Enterprise Holdings Ltd | 13G/A | 0% | May 11, 2026 | 6mo |
| Feis Equities LLC | ARCL ARC Group Acquisition I Corp. | 13G/A | 4.97% | May 11, 2026 | 6mo |
| HESTIA CAPITAL PARTNERS LP | PBI Pitney Bowes Inc | 13D/A | 4.2% | May 11, 2026 | 6mo |
| Onex Corporation | EEX Emerald Holding, Inc. | 13D/A | 93% | May 9, 2026 | 6mo |
| Famatown Finance Ltd. | INSW International Seaways, Inc. | 13D/A | 14.65% | May 8, 2026 | 6mo |
| Saba Capital Management, L.P. | ECAT BlackRock ESG Capital Allocation Term Trust | 13D/A | 20.3% | May 8, 2026 | 6mo |
| SCULLY WILLIAM P | PRTA Prothena Corp Public Ltd Co | 13G/A | 10.3% | May 7, 2026 | 6mo |
| Hilary L Shane Revocable Trust | FONR Fonar Corp | 13G/A | 11.6% | May 7, 2026 | 6mo |
| Saba Capital Management, L.P. | GLO Clough Global Opportunities Fund | 13D/A | 8.18% | May 7, 2026 | 6mo |
| Matrix Capital Management Company, LP | AURA Aura Biosciences, Inc. | 13D/A | 0% | May 7, 2026 | 6mo |
| Access Industries Management, LLC | DOCN DigitalOcean Holdings, Inc. | 13D/A | 21.04% | May 7, 2026 | 6mo |
| Brian Miller | SKIN SkinHealth Systems Inc. | 13D/A | 25.74% | May 7, 2026 | 6mo |
| Lynrock Lake LP | RDCM Radcom Ltd | 13D/A | 15.7% | May 7, 2026 | 6mo |
| Sofinnova Crossover I SLP | ABVX Abivax S.A. | 13D/A | 6.7% | May 7, 2026 | 6mo |
| ADW Capital Partners, L.P. | CODI Compass Diversified Holdings | 13D/A | 17.9% | May 7, 2026 | 6mo |
| SIT INVESTMENT ASSOCIATES INC | MIN Aberdeen Intermediate Income Fund | 13D/A | 28.8% | May 7, 2026 | 6mo |
| BAKER BROS. ADVISORS LP | INCY Incyte Corp | 13D/A | 15.4% | May 7, 2026 | 6mo |
| Alexandra Seros | EVC Entravision Communications Corp | 13D/A | 13.61% | May 7, 2026 | 6mo |
| SC US (TTGP), LTD. | CART Maplebear Inc. | 13D/A | 11.9% | May 7, 2026 | 6mo |
| Liberty Mutual Foundation Inc. | CRGY Crescent Energy Co | 13D/A | 1.3% | May 7, 2026 | 6mo |
| CMLS Holdings LLC | WGS GeneDx Holdings Corp. | 13D/A | 1.8% | May 7, 2026 | 6mo |
| Panacea Venture Healthcare Fund II, L.P. | ATRA Atara Biotherapeutics, Inc. | 13D/A | 16.1% | May 7, 2026 | 6mo |
| HAMPTON FINANCIAL CORP. | ICON Icon Energy Corp | 13G | 10.1% | May 6, 2026 | 6mo |
| GOLDMAN SACHS GROUP INC | SPTX Seaport Therapeutics, Inc. | 13G | 5.5% | May 6, 2026 | 6mo |
| Bin Zhai | CNF CNFinance Holdings Ltd. | 13D | 66.95% | May 6, 2026 | 6mo |
| JANE STREET GROUP, LLC | RIOT Riot Platforms, Inc. | 13G | 5.3% | May 5, 2026 | 6mo |
| AI DEN-MAB LLC | COAG Hemab Therapeutics Holdings, Inc. | 13D | 10.4% | May 4, 2026 | 6mo |
| Stonepine Capital Management, LLC | CLRB Cellectar Biosciences, Inc. | 13G | 9.9% | May 4, 2026 | 6mo |
| RA CAPITAL MANAGEMENT, L.P. | COAG Hemab Therapeutics Holdings, Inc. | 13G | 16.6% | May 4, 2026 | 6mo |
| Paradigm Biocapital Advisors LP | ASMB Assembly Biosciences, Inc. | 13G | 5.4% | May 4, 2026 | 6mo |
| GENERAL ATLANTIC, L.P. | SPTX Seaport Therapeutics, Inc. | 13D | 11.5% | May 4, 2026 | 6mo |
| GLAZER CAPITAL, LLC | TPH Tri Pointe Homes, Inc. | 13G | 5.4% | May 1, 2026 | 6mo |
| Advisors Asset Management, Inc. | IGA Voya Global Advantage & Premium Opportunity Fund | 13G/A | 4.61% | Apr 30, 2026 | 6mo |
| Ramaswamy Vivek | ASST Strive, Inc. | 13D/A | 8.4% | Apr 20, 2026 | 6mo |
| GOLDMAN SACHS GROUP INC | CCIX Churchill Capital Corp IX | 13G/A | 2.9% | Mar 31, 2026 | 6mo |
| Western Standard LLC | OSG Octave Specialty Group Inc | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| MORGAN STANLEY | CBZ CBIZ, Inc. | 13G/A | 3% | Mar 31, 2026 | 6mo |
| GOLDMAN SACHS GROUP INC | OACC Oaktree Acquisition Corp. III Life Sciences | 13G | 6.2% | Mar 31, 2026 | 6mo |
| JANE STREET GROUP, LLC | OSG Octave Specialty Group Inc | 13G/A | 1.7% | Mar 31, 2026 | 6mo |
| NORGES BANK | CE Celanese Corp | 13G | 6.19% | Mar 31, 2026 | 6mo |
| Poplar Point Capital Management LLC | RSKIA George Risk Industries, Inc. | 13G | 5.16% | Mar 31, 2026 | 6mo |
| Opaleye Management Inc. | RZLT Rezolute, Inc. | 13G/A | 6.58% | Mar 31, 2026 | 6mo |
| MORGAN STANLEY | CNM Core & Main, Inc. | 13G/A | 2.7% | Mar 31, 2026 | 6mo |